The bulk-drug compounding industry plays a crucial role in modern healthcare by providing customized medications to meet specific patient needs. As regulatory frameworks evolve and technological advancements enhance compounding capabilities, the industry is experiencing significant growth. According to market research, the bulk-drug compounding market was valued at USD 11.89 billion in 2024 and is projected to reach USD 19.93 billion by 2034, growing at a CAGR of 5.3% from 2025 to 2034. This expansion underscores the increasing demand for personalized medicine and specialized formulations across healthcare sectors.
read more..